Rhythmic Light Therapy for Alzheimer's Disease Patients
Phase 2 - Rhythmic Light Therapy for Alzheimer's Disease Patients
Recruiting
N/A
Interventional Study
Mild Cognitive Impairment
At a Glance
- Age
- 55 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 120 (estimated)
- Sponsor
- Icahn School of Medicine at Mount Sinai · Other
Who this trial is looking for
This trial is looking for people with mild cognitive impairment or mild Alzheimer's disease. Participants will use different types of light treatment over 8 weeks to see how it affects their condition.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been diagnosed with mild cognitive impairment or mild Alzheimer's disease.
- I have a Montreal Cognitive Assessment score between 17 and 25.
- I have sleep disturbances indicated by a score over 5 on the Pittsburgh Sleep Quality Index.
- I live in my own home, independent living, or an assisted living facility.
You may not be able to join if
- I take sleep medication.
- I live in a skilled nursing facility or long-term care.
- I have obstructing cataracts, macular degeneration, or blindness.
- I have severe sleep apnea or restless leg syndrome.
- I have a history of severe epilepsy.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Participants will randomly be placed into one of four groups and experience one of the four following conditions: (1) a placebo light that provides a 40 hertz (Hz) flicker (rhythmic light \[RL\]); (2) a placebo light with a random flicker (placebo condition for rhythmic light); (3) a light source that will stimulate the circadian system and provides a 40 Hz flicker (RL); or (4) a light source that…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Participants must be diagnosed with mild cognitive impairment or mild Alzheimer's disease, as defined by a Montreal Cognitive Assessment score between 17 and 25;
* Have sleep disturbance indicated by a score \>5 on the Pittsburgh Sleep Quality Index
* Participants must reside …
Contacts